Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Eli Lilly's Obesity Business Could Become a Much Bigger Healthcare Platform

Eli Lilly's obesity lead is only the starting point. See what its pipeline, manufacturing build-out, pricing pressure, and earnings trajectory could mean for the stock's next chapter.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Thursday 8 October →